Matches in SemOpenAlex for { <https://semopenalex.org/work/W2281431331> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2281431331 endingPage "70" @default.
- W2281431331 startingPage "67" @default.
- W2281431331 abstract "CHOP has been and still is regarded by many as the 'standard' treatment of advanced non-Hodgkin's lymphoma. In 1980 the EORTC Lymphoma Cooperative Group started a study to evaluate the addition of vincristine and bleomycin to its standard four-drug combination chemotherapy, CHVmP (cyclophosphamide, hydroxorubicin, Vm-26, prednisone). Eligible patients were stage III or IV, intermediate- to high-grade non-Hodgkin's lymphoma (Working Formulation E-I). One-hundred-eighty-nine patients were entered, of whom 140 were eligible and evaluable. A previous report showed an improved response rate and failure-free survival (FFS) and overall survival for the combination CHVmP-VB. At ten years, the outcome still favors the addition of vincristine and bleomycin. The FFS was 34% vs. 23% and the overall survival 34% vs 22%. This difference was mainly due to a difference in CR rate (74% vs. 49%), Relapse-free survival for patients reaching a CR was the same in both arms. When the patients were grouped according to the International Prognostic Factor Index, no statistically significant difference could be observed in favor of one treatment within either group. This trial clearly demonstrates the benefit gained by the addition of vincristine and bleomycin to 'standard' chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma." @default.
- W2281431331 created "2016-06-24" @default.
- W2281431331 creator A5000544997 @default.
- W2281431331 creator A5011489757 @default.
- W2281431331 creator A5011615789 @default.
- W2281431331 creator A5033561428 @default.
- W2281431331 creator A5043162057 @default.
- W2281431331 creator A5070508738 @default.
- W2281431331 creator A5077699515 @default.
- W2281431331 creator A5078995225 @default.
- W2281431331 creator A5087103462 @default.
- W2281431331 creator A5090023600 @default.
- W2281431331 creator A5091674188 @default.
- W2281431331 date "1997-01-01" @default.
- W2281431331 modified "2023-09-23" @default.
- W2281431331 title "Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group." @default.
- W2281431331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9187434" @default.
- W2281431331 hasPublicationYear "1997" @default.
- W2281431331 type Work @default.
- W2281431331 sameAs 2281431331 @default.
- W2281431331 citedByCount "5" @default.
- W2281431331 countsByYear W22814313312021 @default.
- W2281431331 crossrefType "journal-article" @default.
- W2281431331 hasAuthorship W2281431331A5000544997 @default.
- W2281431331 hasAuthorship W2281431331A5011489757 @default.
- W2281431331 hasAuthorship W2281431331A5011615789 @default.
- W2281431331 hasAuthorship W2281431331A5033561428 @default.
- W2281431331 hasAuthorship W2281431331A5043162057 @default.
- W2281431331 hasAuthorship W2281431331A5070508738 @default.
- W2281431331 hasAuthorship W2281431331A5077699515 @default.
- W2281431331 hasAuthorship W2281431331A5078995225 @default.
- W2281431331 hasAuthorship W2281431331A5087103462 @default.
- W2281431331 hasAuthorship W2281431331A5090023600 @default.
- W2281431331 hasAuthorship W2281431331A5091674188 @default.
- W2281431331 hasConcept C126322002 @default.
- W2281431331 hasConcept C141071460 @default.
- W2281431331 hasConcept C143998085 @default.
- W2281431331 hasConcept C146357865 @default.
- W2281431331 hasConcept C151730666 @default.
- W2281431331 hasConcept C2776232574 @default.
- W2281431331 hasConcept C2776694085 @default.
- W2281431331 hasConcept C2776755627 @default.
- W2281431331 hasConcept C2778476748 @default.
- W2281431331 hasConcept C2778720950 @default.
- W2281431331 hasConcept C2779338263 @default.
- W2281431331 hasConcept C2779429289 @default.
- W2281431331 hasConcept C2779725641 @default.
- W2281431331 hasConcept C2780039790 @default.
- W2281431331 hasConcept C71924100 @default.
- W2281431331 hasConcept C86803240 @default.
- W2281431331 hasConcept C90924648 @default.
- W2281431331 hasConceptScore W2281431331C126322002 @default.
- W2281431331 hasConceptScore W2281431331C141071460 @default.
- W2281431331 hasConceptScore W2281431331C143998085 @default.
- W2281431331 hasConceptScore W2281431331C146357865 @default.
- W2281431331 hasConceptScore W2281431331C151730666 @default.
- W2281431331 hasConceptScore W2281431331C2776232574 @default.
- W2281431331 hasConceptScore W2281431331C2776694085 @default.
- W2281431331 hasConceptScore W2281431331C2776755627 @default.
- W2281431331 hasConceptScore W2281431331C2778476748 @default.
- W2281431331 hasConceptScore W2281431331C2778720950 @default.
- W2281431331 hasConceptScore W2281431331C2779338263 @default.
- W2281431331 hasConceptScore W2281431331C2779429289 @default.
- W2281431331 hasConceptScore W2281431331C2779725641 @default.
- W2281431331 hasConceptScore W2281431331C2780039790 @default.
- W2281431331 hasConceptScore W2281431331C71924100 @default.
- W2281431331 hasConceptScore W2281431331C86803240 @default.
- W2281431331 hasConceptScore W2281431331C90924648 @default.
- W2281431331 hasLocation W22814313311 @default.
- W2281431331 hasOpenAccess W2281431331 @default.
- W2281431331 hasPrimaryLocation W22814313311 @default.
- W2281431331 hasRelatedWork W160156331 @default.
- W2281431331 hasRelatedWork W1965824045 @default.
- W2281431331 hasRelatedWork W1996058680 @default.
- W2281431331 hasRelatedWork W2169883104 @default.
- W2281431331 hasRelatedWork W2178567417 @default.
- W2281431331 hasRelatedWork W2281431331 @default.
- W2281431331 hasRelatedWork W2314055277 @default.
- W2281431331 hasRelatedWork W2418293088 @default.
- W2281431331 hasRelatedWork W3032633737 @default.
- W2281431331 hasRelatedWork W2183308400 @default.
- W2281431331 hasVolume "8 Suppl 1" @default.
- W2281431331 isParatext "false" @default.
- W2281431331 isRetracted "false" @default.
- W2281431331 magId "2281431331" @default.
- W2281431331 workType "article" @default.